TF and cancer: Furthermore, both in vitro and in vivo studies showed a vast types of anticancer drugs have been delivered into cancer cells employing a variety of TFR‐binding molecules (such as TF, anti‐TFR antibodies, or TFR‐binding peptides) (Daniels‐wells et al., 2012).